Federated Hermes, Inc. Tricida, Inc. Transaction History

Federated Hermes, Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$8.51 - $13.6 $336,527 - $537,812	39,545 Added 19012.02%	39,753 $417,000
Q2 2022 Aug 15, 2022	SELL	$7.31 - $11.85 $4,415 - $7,157	-604 Reduced 74.38%	208 $2,000
Q1 2022 May 13, 2022	SELL	$7.35 - $10.63 $837 - $1,211	-114 Reduced 12.31%	812 $7,000
Q4 2021 Feb 14, 2022	BUY	$4.19 - $9.56 $3,879 - $8,852	926 New	926 $9,000
Q3 2021 Nov 15, 2021	SELL	$3.56 - $4.64 $3.04 Million - $3.96 Million	-853,099 Closed	0 $0

Q2 2021 Aug 16, 2021	SELL	$3.95 - $5.41 $952,321 - $1.3 Million	-241,094 Reduced 22.03%	853,099 $3.69 Million
Q3 2020 Nov 12, 2020	BUY	$8.56 - $26.93 $6.13 Million - $19.3 Million	716,039 Added 189.35%	1,094,193 $9.91 Million
Q2 2020 Aug 13, 2020	BUY	$21.21 - $31.55 $2.23 Million - $3.31 Million	105,054 Added 38.47%	378,154 $10.4 Million
Q3 2019 Nov 14, 2019	SELL	$29.87 - $42.22 $44,595 - $63,034	-1,493 Reduced 0.54%	273,100 $8.43 Million
Q2 2019 Aug 14, 2019	SELL	$31.16 - $39.46 $5.25 Million - $6.65 Million	-168,507 Reduced 38.03%	274,593 $10.8 Million
Q1 2019 May 10, 2019	BUY	$19.96 - $38.62 $702,592 - $1.36 Million	35,200 Added 8.63%	443,100 $17.1 Million
Q4 2018 Feb 13, 2019	BUY	$23.57 - $32.33 $775,453 - $1.06 Million	32,900 Added 8.77%	407,900 $9.62 Million
Q2 2018 Aug 10, 2018	BUY	$26.0 - $29.9 $9.75 Million - $11.2 Million	375,000 New	375,000 $11.2 Million

30K

124K

46.5K

Ticker TCDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,668,900
Market Cap $557K
Description
Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.